Aim: The aim of the study was to investigate how much magnesium is removed with predilution online hemodiafiltration (with or without glucose in dialysate), compared to conventional hemodialysis. Patients-Methods: The amount of magnesium removed during different dialysis methods (by collecting all the ultrafiltrate in a volumetric barrel) was studied in 27 dialyzed patients, aged 53 - 92 (mean ± SD = 72.0 ± 11.5, median = 73 years), who were on a dialysis program from 12 to 450 months (92.6 ± 91.6 months). In the first group (Group A), with predilution online hemodiafiltration the dialysate had glucose, in the second also with predilution online hemodiafiltration with the same composition of dialysate but without glucose (Group B) and in the third conventional hemodialysis was used (Group C). We determined serum urea and magnesium before and after the end of each session, as well as the volume of the total ultrafiltrate, as well as its urea and magnesium content. Everyone had one session under the conditions mentioned, which were one week apart. Results: Regarding magnesium removal, no significant difference was found with predilution online hemodiafiltration (with and without glucose in dialysate), compared to conventional hemodialysis (p = NS in both cases). The only side effect recorded was hypoglycemia in 3 patients during sessions with glucose-free dialysate, which were treated with intravenous administration of 35% dextrose solution. Conclusion: It is concluded that the amount of magnesium removed is not affected by the method of dialysis (predilution online HDF and conventional hemodialysis), nor from the dialysate used (with or without glucose) or the kind of dialyzer (low or high flux), despite the same clearance given for small molecules (Kt/V and URR).
References
[1]
Jahnen-Dechent, W. and Ketteler, M. (2012) Magnesium Basics. ClinicalKidneyJournal, 5, i3-i14. https://doi.org/10.1093/ndtplus/sfr163
[2]
Navarro‐González, J.F., Mora‐Fernández, C. and García‐Pérez, J. (2009) Reviews: Clinical Implications of Disordered Magnesium Homeostasis in Chronic Renal Failure and Dialysis. SeminarsinDialysis, 22, 37-44. https://doi.org/10.1111/j.1525-139x.2008.00530.x
[3]
Bargnoux, A., Morena, M., Rodriguez, A., Courtais-Coulon, C., Dupuy, A., Kuster, N., et al. (2024) Monitoring of Ionized Magnesium in Hemodialysis Patients: A Useful Tool to Allow a Personalized Prescription of Dialysate Composition. Clinica ChimicaActa, 552, Article 117687. https://doi.org/10.1016/j.cca.2023.117687
[4]
Dyckner, T. and Wester, P.O. (1978) The Relation between Extra‐ and Intracellular Electrolytes in Patients with Hypokalemia and/or Diuretic Treatment. ActaMedicaScandinavica, 204, 269-282. https://doi.org/10.1111/j.0954-6820.1978.tb08438.x
Coburn, J.W., Popovtzer, M.M., Massry, S.G. and Kleeman, C.R. (1969) The Physicochemical State and Renal Handling of Divalent Ions in Chronic Renal Failure. ArchivesofInternalMedicine, 124, 302-311. https://doi.org/10.1001/archinte.1969.00300190042007
[7]
McGill, R.L. and Weiner, D.E. (2017) Dialysate Composition for Hemodialysis: Changes and Changing Risk. SeminarsinDialysis, 30, 112-120. https://doi.org/10.1111/sdi.12573
[8]
Navarro-González, J.F. (1998) Magnesium in Dialysis Patients: Serum Levels and Clinical Implications. ClinicalNephrology, 49, 373-378.
[9]
Kyriazis, J., Kalogeropoulou, K., Bilirakis, L., Smirnioudis, N., Pikounis, V., Stamatiadis, D., et al. (2004) Dialysate Magnesium Level and Blood Pressure. KidneyInternational, 66, 1221-1231. https://doi.org/10.1111/j.1523-1755.2004.00875.x
[10]
Kelber, J., Slatopolsky, E. and Delmez, J.A. (1994) Acute Effects of Different Concentrations of Dialysate Magnesium during High-Efficiency Dialysis. American Journal of Kidney Diseases, 24, 453-460. https://doi.org/10.1016/s0272-6386(12)80902-4
[11]
Vetter, T. and Lohse, M.J. (2002) Magnesium and the Parathyroid. CurrentOpinioninNephrologyandHypertension, 11, 403-410. https://doi.org/10.1097/00041552-200207000-00006
[12]
Liao, F., Folsom, A.R. and Brancati, F.L. (1998) Is Low Magnesium Concentration a Risk Factor for Coronary Heart Disease? The Atherosclerosis Risk in Communities (ARIC) Study. AmericanHeartJournal, 136, 480-490. https://doi.org/10.1016/s0002-8703(98)70224-8
[13]
Reffelmann, T., Ittermann, T., Dörr, M., Völzke, H., Reinthaler, M., Petersmann, A., et al. (2011) Low Serum Magnesium Concentrations Predict Cardiovascular and All-Cause Mortality. Atherosclerosis, 219, 280-284. https://doi.org/10.1016/j.atherosclerosis.2011.05.038
[14]
Ishimura, E., Okuno, S., Yamakawa, T., Inab, M. and Nishizawa, Y. (2007) Serum Magnesium Concentration Is a Significant Predictor of Mortality in Maintenance Hemodialysis Patients. MagnesiumResearch, 20, 237-244.
[15]
Lacson, E., Wang, W., Ma, L. and Passlick-Deetjen, J. (2015) Serum Magnesium and Mortality in Hemodialysis Patients in the United States: A Cohort Study. AmericanJournalofKidneyDiseases, 66, 1056-1066. https://doi.org/10.1053/j.ajkd.2015.06.014
[16]
Li, L., Streja, E., Rhee, C.M., Mehrotra, R., Soohoo, M., Brunelli, S.M., et al. (2015) Hypomagnesemia and Mortality in Incident Hemodialysis Patients. AmericanJournalofKidneyDiseases, 66, 1047-1055. https://doi.org/10.1053/j.ajkd.2015.05.024
[17]
Pun, P.H. and Middleton, J.P. (2017) Dialysate Potassium, Dialysate Magnesium, and Hemodialysis Risk. JournaloftheAmericanSocietyofNephrology, 28, 3441-3451. https://doi.org/10.1681/asn.2017060640
[18]
Mavromatidis, K.S., Kalogiannidou, I.M., Kriki, P.A., Impis, E.S. and Achmet, G.J.K. (2025) Changes in Serum Magnesium after Increasing Dialysate Magnesium in Hemodialysis Patients: A Prospective Case Series. JournalofBiosciencesandMedicines, 13, 74-88. https://doi.org/10.4236/jbm.2025.1311007
[19]
Wyskida, K., Witkowicz, J., Chudek, J. and Więcek, A. (2012) Daily Magnesium Intake and Hypermagnesemia in Hemodialysis Patients with Chronic Kidney Disease. JournalofRenalNutrition, 22, 19-26. https://doi.org/10.1053/j.jrn.2011.03.001
[20]
Dekker, F.W., de Mutsert, R., van Dijk, P.C., Zoccali, C. and Jager, K.J. (2008) Survival Analysis: Time-Dependent Effects and Time-Varying Risk Factors. KidneyInternational, 74, 994-997. https://doi.org/10.1038/ki.2008.328
[21]
Rius Peris, A., Hernández-Jaras, J., Pons, R., García Pérez, H., Torregrosa, E., Sánchez Canel, et al. (2007) Kinetics of Calcium, Phosphate, and Magnesium and PTH Variations during Hemodiafiltration. Nefrologia, 27, 593-598.
[22]
Leenders, N.H.J., Douma, C.E., Hoenderop, J.G.J. and Vervloet, M.G. (2022) Magnesium in Chronic Haemodialysis (MAGIC-HD): A Study Protocol for a Randomised Controlled Trial to Determine Feasibility and Safety of Using Increased Dialysate Magnesium Concentrations to Increase Plasma Magnesium Concentrations in People Treated with Haemodialysis. BMJOpen, 12, e063524. https://doi.org/10.1136/bmjopen-2022-063524
[23]
Alhosaini, M. and Leehey, D.J. (2015) Magnesium and Dialysis: The Neglected Cation. AmericanJournalofKidneyDiseases, 66, 523-531. https://doi.org/10.1053/j.ajkd.2015.01.029
[24]
Hwang, D.L., Yen, C.F. and Nadler, J.L. (1993) Insulin Increases Intracellular Magnesium Transport in Human Platelets. TheJournalofClinicalEndocrinology&Metabolism, 76, 549-553. https://doi.org/10.1210/jcem.76.3.8445010
[25]
Kostov, K. (2019) Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and Signaling. InternationalJournalofMolecularSciences, 20, Article 1351. https://doi.org/10.3390/ijms20061351
[26]
Navarrete-Cortes, A., Ble-Castillo, J.L., Guerrero-Romero, F., Cordova-Uscanga, R., Juárez-Rojop, I.E., Aguilar-Mariscal, H., et al. (2014) No Effect of Magnesium Supplementation on Metabolic Control and Insulin Sensitivity in Type 2 Diabetic Patients with Normomagnesemia. MagnesiumResearch, 27, 48-56. https://doi.org/10.1684/mrh.2014.0361
[27]
Leenders, N.H.J., van Ittersum, F.J., Hoekstra, T., Hoenderop, J.G.J. and Vervloet, M.G. (2018) Routine Hemodialysis Induces a Decline in Plasma Magnesium Concentration in Most Patients: A Prospective Observational Cohort Study. ScientificReports, 8, Article No. 10256. https://doi.org/10.1038/s41598-018-28629-x
[28]
Han, Z., Zhou, L., Liu, R. and Feng, L. (2020) The Effect of Hemodialysis on Serum Magnesium Concentration in Hemodialysis Patients. AnnalsofPalliativeMedicine, 9, 1134-1143. https://doi.org/10.21037/apm-20-992
[29]
Balzer, M.S., Müller-Deile, J., Schulze, D.I., Elizabeth, G., Schmidt, B.M.W., Haller, H., et al. (2016) Potential Impact of Dialysate Magnesium on Intradialytic Hypotension. ArchivesRenalDiseasesandManagement, 2, 31-34.
[30]
Sakaguchi, Y., Fujii, N., Shoji, T., Hayashi, T., Rakugi, H. and Isaka, Y. (2014) Hypomagnesemia Is a Significant Predictor of Cardiovascular and Non-Cardiovascular Mortality in Patients Undergoing Hemodialysis. KidneyInternational, 85, 174-181. https://doi.org/10.1038/ki.2013.327
[31]
Sakaguchi, Y., Fujii, N., Shoji, T., Hayashi, T., Rakugi, H., Iseki, K., et al. (2014) Magnesium Modifies the Cardiovascular Mortality Risk Associated with Hyperphosphatemia in Patients Undergoing Hemodialysis: A Cohort Study. PLOSONE, 9, e116273. https://doi.org/10.1371/journal.pone.0116273
[32]
Tanaka, Y., Shima, H., Hatonari, R., Okada, D., Michiwaki, H., Wariishi, S., et al. (2021) Effects of On-Line Hemodiafiltration Regimens and Dialysate Composition on Serum Concentrations of Magnesium and Calcium Ions. Renal Replacement Therapy, 7, Article No. 26. https://doi.org/10.1186/s41100-021-00345-9
[33]
Barbagallo, M. and Dominguez, L.J. (2007) Magnesium Metabolism in Type 2 Diabetes Mellitus, Metabolic Syndrome and Insulin Resistance. ArchivesofBiochemistryandBiophysics, 458, 40-47. https://doi.org/10.1016/j.abb.2006.05.007
